Literature DB >> 1582819

Patients' attitudes toward informed consent for intravenous contrast media.

K D Hopper1, P S Houts, M A McCauslin, Y L Matthews, R J Sefczek.   

Abstract

OBJECTIVES: To assess patient attitudes concerning informed consent and the risks of ionic and nonionic contrast material, 1,197 completed questionnaires were obtained from individuals either awaiting contrast injection or waiting for other services.
METHODS: Six different questionnaire formats were administered, including two detailing the specific risks of ionic and nonionic contrast, respectively. Different questionnaire formats were used to assess whether the severity or the probability of adverse consequences had more influence on a patient's desire for information. Two questionnaires evaluated the effect of comparing medical risks to equivalent risks from everyday nonmedical activities. RESULTS AND
CONCLUSIONS: Regardless of questionnaire format and the severity of potential risk, the large majority of individuals want some information before contrast injection, and approximately half view such information as essential. Individuals reacted more to the probability of a potential reaction than its severity, and to items ordered toward the end of a particular questionnaire than at the beginning.

Entities:  

Keywords:  Empirical Approach; Professional Patient Relationship

Mesh:

Substances:

Year:  1992        PMID: 1582819     DOI: 10.1097/00004424-199205000-00009

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  2 in total

1.  Patient attitudes to myelography, computed tomography and magnetic resonance imaging when examined for suspected lumbar disc herniation.

Authors:  M J Albeck; B Danneskiold-Samsøe
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 2.  Use of contrast media in diagnostic imaging: medico-legal considerations.

Authors:  C Pomara; N Pascale; F Maglietta; M Neri; I Riezzo; E Turillazzi
Journal:  Radiol Med       Date:  2015-06-17       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.